1. Home
  2. COCP vs TGHL Comparison

COCP vs TGHL Comparison

Compare COCP & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.18

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

Logo The GrowHub Limited Class A Ordinary Shares

TGHL

The GrowHub Limited Class A Ordinary Shares

N/A

Current Price

$0.84

Market Cap

20.4M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
TGHL
Founded
2006
2020
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
20.4M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
COCP
TGHL
Price
$1.18
$0.84
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
54.9K
272.6K
Earning Date
05-15-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
N/A
EPS
N/A
N/A
Revenue
$12,712,091.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.27
52 Week High
$2.03
$2.48

Technical Indicators

Market Signals
Indicator
COCP
TGHL
Relative Strength Index (RSI) 55.04 49.72
Support Level $0.91 $0.33
Resistance Level $1.22 $0.95
Average True Range (ATR) 0.07 0.07
MACD 0.00 0.00
Stochastic Oscillator 36.84 44.33

Price Performance

Historical Comparison
COCP
TGHL

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About TGHL The GrowHub Limited Class A Ordinary Shares

The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.

Share on Social Networks: